UBS Group’s CM Life Sciences, Inc. Unit CMLFU Stock Holding History

UBS Group’s Portfolio CMLFU Stock Details CMLFU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,030	Closed	-$16K	–	10769
2021 Q2	$16K	Sell	1,030 -646	-39%	-$9.35K	﹤0.01%	7622
2021 Q1	$28K	Sell	1,676 -12,063	-88%	-$212K	﹤0.01%	7084
2020 Q4	$159K	Buy	+13,739	New	+$148K	﹤0.01%	5386

UBS Group's CMLFU Position: Q3 2021 in Review

UBS Group sold out of CM Life Sciences, Inc. Unit (CMLFU) in Q3 2021, closing a stake of 1,030 shares — an estimated $16K sold.

UBS Group first reported a position in CMLFU in Q4 2020 and held it in 3 quarters. The position peaked at $159K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMLFU as of Q3 2021.

UBS Group reported no remaining CM Life Sciences, Inc. Unit position as of Q3 2021 after selling out during the quarter.
UBS Group sold 1,030 CM Life Sciences, Inc. Unit shares in Q3 2021, an estimated $16K.
UBS Group first reported a position in CM Life Sciences, Inc. Unit in Q4 2020 and held it in 3 quarters.
UBS Group's CM Life Sciences, Inc. Unit position peaked at $159K in Q4 2020.
0 funds tracked by Wall St. Rank held CM Life Sciences, Inc. Unit as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.